Develop Commercial Strategy for MHRA Scientific Advice Services

The Medicines and Healthcare Products Regulatory Agency (MHRA) seeks consultancy support to develop a commercialisation strategy for its scientific advice services. The MHRA faces increasing demand for its services and needs to improve service quality, predictability, and competitiveness while aligning with its 2030 Strategy. This opportunity requires consultants to conduct market analysis and stakeholder engagement to inform a sustainable commercial model. Deliverables include: (1) an assessment of MHRA's unique market strengths and five to ten critical hypotheses about demand and operational requirements for commercialising scientific advice services such as clinical trial advice, licensing guidance, and post-marketing surveillance; (2) synthesis of ten to twenty interviews with industry experts and MHRA staff, plus secondary research to define market demand, identify specific services and pricing models, and outline operational requirements; and (3) a board-ready presentation with a compelling and sustainable core service offering that preserves MHRA's independent regulatory authority, plus a high-level roadmap for implementation and value realisation.